Paracetamol Grünenthal

Quick links

Choose a section

Quick links to important sections

Advertisements

Paracetamol Grünenthal

Advertisements
Advertisements

Overview of Paracetamol Grünenthal

Property Description
Active ingredient Paracetamol (Acetaminophen)
Pharmacological class Non-opioid analgesic, Antipyretic
Origin Synthetic (Aniline derivative)
Common purpose Symptomatic relief of mild to moderate pain and fever
Forms Tablets, solutions, suppositories, parenteral formulations

Defining Paracetamol Grünenthal: Identity, Class, and Composition

Paracetamol Grünenthal is a medicinal product marketed by the company Grünenthal, featuring the single active substance Paracetamol, internationally recognized as Acetaminophen (APAP). It is a synthetic aniline derivative classified pharmacologically as a non-opioid analgesic and antipyretic. The core composition features this single active ingredient, making it a monotherapy. The compound is used for its focused action in reducing elevated temperatures and pain perception.


Forms and Core Purpose: What Paracetamol Grünenthal Generally Helps

The medicine is manufactured in various dosage forms, including traditional tablets, effervescent tablets, solutions, suppositories, and specialized parenteral formulations (e.g., intravenous infusion), allowing for oral, rectal, or intravenous administration. This breadth of formulation and administration positions it for use in diverse patient groups. As both an analgesic and antipyretic, its essential purpose is to provide focused symptomatic relief by alleviating mild to moderate pain and reducing fever (pyrexia). Paracetamol is considered a reliable tool for core health needs.

Regulatory References

  1. World Health Organization (WHO) | Essential Medicines List
  2. WHO Electronic Essential Medicines List (eEML)
Advertisements

What side effects are possible with Paracetamol Grünenthal?

Possible side effects and safety information

The official safety profile for Paracetamol (Acetaminophen) centers on the risk of hepatotoxicity and the classification of other adverse events by frequency and system-organ class, based strictly on government regulatory documents.

Key Safety Concerns and Frequencies

Adverse reactions are formally grouped, with the majority of serious effects classified as rare or very rare when the medicine is used at recommended therapeutic doses. The most significant concern is the potential for acute liver failure (hepatotoxicity), which is primarily associated with exceeding the maximum recommended dosage.

Classification Examples of Officially Listed Effects
Hepatobiliary Disorders Hepatic injury, acute liver failure
Blood Disorders Thrombocytopenia, agranulocytosis, neutropenia
Immune Disorders Hypersensitivity reactions, anaphylactic shock
Skin Disorders Rash, pruritus, severe skin reactions (SJS, TEN)

Serious Adverse Reactions and Safety Constraints

Regulatory documents explicitly list rare but severe systemic reactions, including anaphylaxis and severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Safety constraints mandate that the medicine is contraindicated in patients with known hypersensitivity to the active substance and in cases of severe hepatic insufficiency. Special caution is necessary for individuals with risk factors for glutathione depletion, such as those with chronic alcohol abuse or severe malnutrition, as this state can increase susceptibility to toxicity. The product label strictly prohibits using this medicine with any other product containing Paracetamol to prevent accidental dose exceedance.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose Profile Summary

Overdose of paracetamol carries a significant risk of severe, delayed organ damage, principally fatal hepatic necrosis (liver damage). This risk is independent of the initial presentation, as patients may be asymptomatic or experience only mild, non-specific symptoms such as nausea, vomiting, pallor, and abdominal pain within the first 24 hours.

Documented Manifestations and Serious Outcomes

Manifestation Type Examples
Early Symptoms Pallor, Nausea, Vomiting, Abdominal pain
Serious Outcomes Hepatic necrosis, Acute renal failure (tubular necrosis), Metabolic acidosis, Encephalopathy

Emergency Action and Treatment

Immediate medical advice must be sought in the event of an overdose, even if the patient feels well. The requirement for urgent care is based on the risk of delayed, serious liver damage. The established treatment involves the prompt administration of the specific antidote, N-acetylcysteine (NAC), which is most effective if given within eight hours of ingestion. Hospital management includes close monitoring of plasma paracetamol concentration (typically measured at four hours or later) and monitoring liver function tests.

Population-Specific Risks

Individuals with pre-existing conditions, particularly non-cirrhotic alcoholic liver disease, or those with risk factors for glutathione depletion (e.g., chronic malnutrition), face a heightened hazard from overdose.

Advertisements

Therapeutic Uses of Paracetamol Grünenthal

What Paracetamol Grünenthal Treats: Main Uses and Benefits

The fundamental purpose of Paracetamol Grünenthal is to offer symptomatic relief by assisting in the management of two primary domains: pain and fever. The medication is commonly used for the symptomatic management of mild to moderate pain and/or fever. It is applied in situations involving acute or disruptive symptom patterns, generally when discomfort becomes noticeable and interferes with daily stability, providing supportive therapeutic benefit during these episodes.

Primary Therapeutic Scope

Paracetamol Grünenthal is relevant in conditions marked by heightened symptoms, such as the tension headache, dental pain, and menstrual cramps (primary dysmenorrhea) associated with the analgesic domain, as well as the high temperature (pyrexia) and body aches linked to seasonal viral illnesses like the cold or flu. Applied in contexts where additional supportive symptom management is appropriate, it contributes to improved day-to-day comfort.

“It provides supportive relief when symptoms interfere with routine activities, may help patients cope more easily during difficult episodes.”

Clinical Scenarios and Benefit

This medication is often used when symptoms intensify and supportive relief is needed, such as in the home management of minor ailments, or following minor procedures like dental work or immunization. Its use supports the overall symptom burden of painful manifestations and may assist with maintaining functional stability during episodes of heightened discomfort.

Quick Fact: Symptomatic Relief
Symptom Severity: Mild to moderate discomfort and elevated temperature.
Common Use: Management of acute, episodic symptom patterns.
Patient Benefit: Supports general well-being during symptomatic phases.

Regulatory References

  1. European Public Assessment Report
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Paracetamol Grünenthal?

The eligibility for using Paracetamol Grünenthal is defined by official regulatory labeling, which establishes absolute prohibitions (contraindications) and conditional use requirements across different populations.

Contraindications (Must Not Use)

  • Known Hypersensitivity: Patients with a history of allergy or known hypersensitivity to the active substance paracetamol or any of the product's excipients must not use this medicine.
  • Severe Hepatic Impairment: Use is generally contraindicated for individuals with severe liver disease.

Conditional Eligibility

Population Group Regulatory Status Key Restriction/Caution
Adults and Adolescents Generally Eligible Minimum age thresholds apply (e.g., ge 10 years for some forms).
Pediatric Use Restricted Not recommended for children below specified age or weight cut-offs; specialized low-dose forms are required.
Pregnancy Permitted (Conditional) Use is restricted to the lowest effective dose, for the shortest duration, when clinically necessary.
Renal/Hepatic Insufficiency Caution Required Patients with severe renal insufficiency or mild to moderate hepatic insufficiency (including Gilbert's syndrome) may require dose limitation.
Risk Factors Caution Required Conditions like chronic malnutrition, dehydration, or chronic alcohol abuse require caution due to increased risk of toxicity.

Conclusion

Eligibility is contingent upon meeting specific health criteria documented in the product label. Regulatory guidelines ensure that use in vulnerable groups is strictly limited or conditional, prohibiting use where the risk of harm is officially classified as unacceptably high.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines clinically significant interactions involving Paracetamol (Acetaminophen) as documented in official regulatory sources. Concomitant use with other medicinal products containing paracetamol is strictly restricted to prevent accidental overdose and severe liver toxicity.


Pharmacodynamic and Safety Interactions

Interacting Substance/Class Documented Interaction Constraint/Requirement
Oral Anticoagulants (e.g., Warfarin) Regular, prolonged use may potentiate the anticoagulant effect, increasing the risk of bleeding. Coagulation parameters (e.g., INR) require closer monitoring.
Zidovudine Increased risk of neutropenia (low white blood cell count). Use with caution and clinical observation.
Chronic Alcohol Use Significantly increased risk of hepatotoxicity. Explicit warnings against chronic excessive alcohol ingestion.
Flucloxacillin Associated with increased risk of high anion gap metabolic acidosis. Higher risk in predisposing conditions (e.g., severe renal impairment, sepsis).

Pharmacokinetic Interactions

Interacting Substance/Class Mechanism/Effect Constraint/Requirement
Probenecid Inhibits conjugation, reducing paracetamol clearance and increasing exposure. Dose reduction of paracetamol may be necessary.
Metoclopramide / Domperidone Accelerate gastric emptying, increasing the rate of paracetamol absorption. Affects onset of action, but not total exposure (AUC).
Cholestyramine Reduces the absorption of paracetamol. Dosing requires separation by at least one hour.
Enzyme Inducers (e.g., Phenytoin, Carbamazepine, Rifampicin) Increase the formation of the toxic metabolite. Requires caution due to elevated hepatotoxicity risk.
Advertisements

Mechanism of Action

How Paracetamol Grünenthal Works

The mechanism of action for Paracetamol Grünenthal primarily involves engagement with multiple key signaling pathways within the central nervous system (CNS), resulting in distinct physiological adjustments.


Inhibition of Central Cyclooxygenase (COX) Activity

The drug acts by inhibiting cyclooxygenase (COX) enzymes in the CNS. This enzyme-mediated signaling modification reduces the synthesis of prostaglandins (PGs), particularly prostaglandin E2 ( PGE2). By modifying these early molecular steps, the mechanism influences localized downstream signal transduction, resulting in the localized reduction of central thermoregulatory pathway activity and decreased nociceptive signal transduction.


Metabolite Interaction with TRPV1 Receptors

Its metabolite, N-(4-hydroxyphenyl)arachidonoylamide ( AM404), which is formed within the CNS, modulates key pathways associated with signal transmission. AM404 acts as an agonist at the Transient Receptor Potential Vanilloid 1 ( TRPV1) receptors and potentially interacts with CB1 receptors. This mechanism affects the signal threshold in nociceptive pathways.


Modulation of Descending Serotonergic Pathway Activity

Paracetamol also affects the descending serotonergic pain pathway in the spinal cord. This influence on 5-HT (serotonin) signaling results in the modulation of the neurotransmitter release profile within the descending pain pathway, thereby modifying nociceptive signal output.

Advertisements

Dosage and Administration Information

Administration Scope and Dosage

Paracetamol, the active substance in Paracetamol Grünenthal, is administered via several routes, including oral ingestion, rectal insertion via suppositories, and intravenous (IV) infusion for specific clinical settings. This breadth of formulation allows for use across diverse patient needs. Oral forms may be taken with or without food, though consumption on an empty stomach may result in a faster onset of action.

For adults, the standard single oral dose ranges from 500 mg to 1 g. The medication is scheduled according to a minimum interval of four to six hours between doses to prevent exceeding the Maximum Total Daily Dose (MTDD). The MTDD is typically established at 4 g in a 24-hour period for standard adult use, with a reduction to 3 g or less often required in individuals with known risk factors such as chronic hepatic impairment. Patients must not take this product concurrently with other paracetamol-containing medicines.

Frequency and Special Conditions

Administration frequency must not exceed four doses within any 24-hour cycle. This dosing pattern is critical, and for patients diagnosed with severe renal impairment (creatinine clearance less than or equal to 30 mL/min), the minimum interval between administrations must be extended to a minimum of six hours. In cases where the medicine is administered parenterally, the intravenous solution must be given as a controlled 15-minute infusion. For short-term, non-prescriptive use, the duration of therapy is generally restricted, typically not exceeding three days for fever.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Paracetamol Grünenthal

Research into Short-Term and Acute Pain

Research has primarily explored this medication in studies examining patient-reported experiences for conditions associated with acute or disruptive episodes, such as headache or toothache. These studies are used in research exploring how symptoms change over time and focus on outcomes related to physical discomfort.

Studies examined whether the medication was associated with short-term changes in patient-reported outcomes describing perceived discomfort. The research describes how symptoms evolved in the observed populations over brief periods. These findings help contextualize how patients reported their experience during episodes where symptoms became more noticeable.

However, the evidence is limited when examining its use across all different types of acute pain, and the exact findings sometimes vary. Research provides context but not individual predictions, meaning study results reflect the specific conditions under which they were conducted. Individual responses may vary, and research does not determine whether an individual will respond similarly.


Research into Fever and High Temperature

Studies have monitored the medication’s use for conditions involving periods of heightened symptoms, specifically for high body temperature, or fever. This research was relevant in trials assessing short-term or episodic symptom patterns and focused on outcomes related to systemic or functional imbalance.

The data show patterns related to temporary changes measured during the study period. Data show patterns related to temporary changes in temperature observed in the short intervals over which the patients were monitored. Evidence contributes to understanding these symptom patterns and suggests that the medication was associated with temporary changes in temperature, which may reflect physiological strain or stress.

Certainty remains low for some aspects, such as how the effect compares to other options in specific, smaller patient groups. The short-term nature of these studies is a limitation. Long-term effects are not fully established. Comparative evidence is lacking in some areas, and follow-up durations were limited across much of the research.


Evidence for Long-Term or Chronic Conditions

The medication was evaluated in studies exploring chronic conditions characterized by fluctuating or episodic manifestations. Research in this area has explored daily-life functioning and conditions where symptoms may vary in intensity, particularly in areas like chronic musculoskeletal discomfort.

Studies explored outcomes reflecting daily functioning or activity level. Findings were mixed when examining patterns of sustained change over long periods for chronic conditions. Data show patterns related to temporary or episodic symptom control, but evidence suggests limited or uncertain results when looking at outcomes reflecting long-term functional improvement in some conditions.

Research highlights what is known—and what is still uncertain. Information about long-term changes across all chronic conditions remains limited.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Grünenthal (FAQ)


Q: What kind of pain is Paracetamol Grünenthal primarily used for?

A: According to official regulatory documents, this medicine is indicated for the symptomatic relief of mild to moderate pain and fever. While it is commonly used for everyday issues like headaches and toothaches, its indication covers a wide variety of mild to moderate pain types.

Q: Can Paracetamol Grünenthal be used for muscle pain or sprains?

A: The medicine is indicated for the symptomatic relief of mild to moderate pain. This spectrum of pain often includes muscle pain or discomfort from sprains. The suitability for specific types of pain should always be determined by a healthcare professional.

Q: Is Paracetamol Grünenthal effective for tension headaches or migraines?

A: As an analgesic, the medication is indicated for the relief of mild to moderate pain, which includes general headaches. Regulatory research studies have specifically explored its use for headache symptoms.

Q: Can Paracetamol Grünenthal be used by children, and if so, what is the age limit?

A: Yes, Paracetamol can be used in children, but its use is restricted and generally not recommended for children below specified age or weight cut-offs in the standard forms. Specialized low-dose formulations are usually required for pediatric use.

Q: Is it normal to feel slightly nauseous after taking Paracetamol Grünenthal?

A: Nausea has been reported, especially in cases where the recommended dose is exceeded. While it is not typically listed as a common side effect at therapeutic doses in official safety information, if you experience any persistent or concerning symptoms, contact a healthcare professional.

Q: Can taking Paracetamol Grünenthal long-term cause kidney issues?

A: Adverse effects on the kidneys have been reported, but they are generally classified as rare when the medicine is used at recommended doses. Regulatory documents state that caution is required for patients with severe renal (kidney) impairment, as the dosing interval may need adjustment.

Q: What are the signs of a potential liver problem when taking paracetamol?

A: Symptoms of liver damage or overdose, which is the most significant safety concern, can include nausea, vomiting, lack of appetite, discomfort in the upper right side of the abdomen, and yellowing of the skin or eyes (jaundice). If you notice these serious signs, you must contact emergency medical services or a healthcare provider immediately.

Q: Can Paracetamol Grünenthal cause an upset stomach?

A: The medication is generally well tolerated by the stomach. However, gastrointestinal effects, such as upset stomach, have been reported. If you experience persistent or concerning discomfort, contact a healthcare professional.

Q: Is Paracetamol Grünenthal used to treat post-operative pain?

A: As an analgesic indicated for mild to moderate pain, Paracetamol is frequently used as a component of post-operative pain management regimens in clinical settings.

Q: What is the risk of skin reactions (like rash or hives) from Paracetamol Grünenthal?

A: Official safety information lists skin reactions, including rash and pruritus (itching), as potential adverse reactions. Severe skin reactions (SCARs), such as Stevens-Johnson syndrome, are also listed but are classified as rare.

Q: Can this medication affect blood sugar test results?

A: Yes, official product information indicates that Paracetamol may affect blood sugar tests that utilize the glucose-oxidase-peroxidase analytical method.

Q: Does Paracetamol Grünenthal come in different strengths?

A: Yes, Paracetamol is manufactured in different strengths (for example, 500 mg or 1 g) and forms, such as tablets, solutions, and suppositories, to allow for appropriate administration to adults and children.

Q: Does Paracetamol Grünenthal interact with prescription medications for epilepsy?

A: Yes, caution is advised when taking this medicine with certain enzyme-inducing medicines, such as those used to treat epilepsy (e.g., Phenytoin, Carbamazepine). This combination may increase the risk of toxicity.

Q: Can Paracetamol Grünenthal be used for period pain (dysmenorrhea)?

A: The medication is indicated for the relief of mild to moderate pain. Period pain, or dysmenorrhea, is a type of pain that may be treated with Paracetamol.

Q: What happens if I miss a dose of Paracetamol Grünenthal?

A: If you miss a dose, official instructions advise you to take it as soon as you remember, unless it is almost time for the next scheduled dose. If so, you should skip the missed dose and continue with your regular schedule. It is important not to take a double dose to compensate for a missed one.

Q: How is Paracetamol Grünenthal metabolized (broken down) in the body?

A: Paracetamol is primarily metabolized (broken down) extensively in the liver and then excreted in the urine. A small portion is converted into a toxic intermediate that the body typically clears using a substance called glutathione.

Q: Is there any research on Paracetamol Grünenthal's effectiveness in chronic pain compared to acute pain?

A: Official research covers both acute pain (like sudden headaches) and chronic conditions (like musculoskeletal discomfort). Studies show that while it can help with temporary symptoms in chronic pain, findings on long-term functional improvement are often mixed or limited.

Q: Does Paracetamol Grünenthal cause drowsiness or affect my ability to drive?

A: Official product information states that Paracetamol is generally not associated with drowsiness or significant effects on the ability to drive or operate machinery when taken at recommended doses.

Q: Can taking Paracetamol Grünenthal cause problems for people with asthma?

A: Yes, caution is advised for patients with asthma who are sensitive to aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), as mild bronchospasms have been reported in association with Paracetamol.

Q: Does taking Paracetamol Grünenthal affect fertility?

A: Official product information notes that, based on post-marketing reports, Paracetamol may impair female fertility. However, this effect is considered to be reversible upon stopping the drug.

Q: What is the evidence regarding Paracetamol Grünenthal's use for low back pain?

A: Research has explored the medication's use for chronic musculoskeletal discomfort. However, evidence regarding its effectiveness for sustained improvement in specific conditions like low back pain is often considered limited or uncertain.

Q: Can a person take Paracetamol Grünenthal while breastfeeding?

A: Clinical data indicate that Paracetamol can generally be used during breastfeeding. The use of any medication while breastfeeding should be discussed with a healthcare professional.

Advertisements

How should Paracetamol Grünenthal be stored and disposed of?

Storage and Disposal Requirements for Paracetamol (Grünenthal)

The storage and disposal of this medicine must comply with official regulatory standards to maintain its quality and ensure environmental safety.

Required Storage Conditions

Constraint Regulatory Requirement
Temperature Do not store above 25 C.
Protection Store in the original package to protect from light and moisture.
Child Safety Keep this medicine out of the sight and reach of children (Mandatory).
Shelf-Life Do not use after the expiry date (EXP) printed on the packaging.

Official Disposal Instructions

Unused or expired Paracetamol must not be thrown away via wastewater or household waste. This environmental restriction requires patients to ask a pharmacist how to dispose of the medicine properly.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Grünenthal found in:

A-Z Index: